Similar Items: Back Cover: Identification of genetically predicted protein biomarkers and drug targets for prostate cancer via Mendelian randomization (View 3/2026)
- Identification of genetically predicted protein biomarkers and drug targets for prostate cancer via Mendelian randomization
- Cover Picture: Nanobody–chlorin e6 conjugate for Nectin‐4‐mediated tumor targeting and enhanced photodynamic therapy (View 3/2026)
- Back Cover: In situ monitoring of cell adhesion kinetics using label‐free optical biosensors: Evaluating anticancer potential and selectivity of natural compounds (View 2/2026)
- Protein modification systems as cancer biomarkers and therapeutic targets
- Inside Front Cover: Tumour‐informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post‐treatment (View 2/2026)
- Masthead: (View 3/2026)